Investment Pitch media Logo  300 DPI Transparent BG (use).png
InvestmentPitch Media Video Discusses FSD Pharma’s Granting of Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technology to Celly Nutrition
June 23, 2023 06:00 ET | InvestmentPitch Media and FSD Pharma
VANCOUVER, British Columbia, June 23, 2023 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets...
Investment Pitch media Logo  300 DPI Transparent BG (use).png
InvestmentPitch Media Video Discusses FSD Pharma’s Cost Award of $2.81 Million from Dr. Raza Bokhari in an Arbitration Settlement
May 16, 2023 06:00 ET | InvestmentPitch Media and FSD Pharma
VANCOUVER, British Columbia, May 16, 2023 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets...
Investment Pitch media Logo  300 DPI Transparent BG (use).png
InvestmentPitch Media Video Discusses FSD Pharma’s Addition of Kevin Harrington, Author, “Shark Tank” Original, and Infomercial Pioneer to its Advisory Board
March 01, 2023 06:00 ET | InvestmentPitch Media and FSD Pharma
VANCOUVER, British Columbia, March 01, 2023 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative...
Investment Pitch media Logo  300 DPI Transparent BG (use).png
InvestmentPitch Media Video Discusses FSD Pharma’s Announcement that the Claim for US$30.2 Million Brought by Dr. Raza Bokhari, the Company’s Former CEO, has been Dismissed in its Entirety
November 15, 2022 06:00 ET | InvestmentPitch Media and FSD Pharma
VANCOUVER, British Columbia, Nov. 15, 2022 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets...
Investment Pitch media Logo  300 DPI Transparent BG (use).png
InvestmentPitch Media Video Discusses FSD Pharma’s Submission of an Investigational New Drug or “IND” Application with the U.S. Food and Drug Administration and Health Canada for Treatment of a Yet-To-Be-Disclosed Inflammatory Disorder
June 01, 2022 06:00 ET | InvestmentPitch Media and FSD Pharma
VANCOUVER, British Columbia, June 01, 2022 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a life sciences holding company dedicated to building a portfolio of assets and...
Investment Pitch media Logo  300 DPI Transparent BG (use).png
InvestmentPitch Media Video Discusses FSD Pharma, a Life Sciences Holding Company, and the Closing of its Sale of Non-Core Assets for $16.4 million
May 11, 2022 06:00 ET | InvestmentPitch Media and FSD Pharma
VANCOUVER, British Columbia, May 11, 2022 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a life sciences holding company dedicated to building a portfolio of assets and...
Investment Pitch media Logo  300 DPI Transparent BG (use).png
InvestmentPitch Media Video Discusses FSD Pharma’s, a Life Sciences Holding Company, Agreement to Sell Former Cannabis Processing Facility in Cobourg, Ontario for $16,500,000 – Video Available on Investmentpitch.com
February 28, 2022 03:10 ET | InvestmentPitch Media and FSD Pharma
VANCOUVER, British Columbia, Feb. 28, 2022 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9), a life sciences holding company dedicated to building a portfolio of assets and...